IMMUTEP Ltd
IMMP- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001506184
No open-market purchases or sales by IMMUTEP Ltd insiders were filed in the last 90 days; 25 institutions reported holding it in 13F filings for Q2 2026, worth $692.0K in total; no superinvestor holds it.
Other share classesPRRUF
Q3 2022 vs. Q2 2022
How the institutions holding IMMUTEP Ltd changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Q3 2022 | Change |
|---|---|---|---|
| Holders | 22 | 21 | −1 |
| Shares | 5.54M | 5.33M | −210.0K (−3.8%) |
| Value | $11.2M | $8.31M | −$2.93M (−26.1%) |
New holders (3)
Institutions that held IMMUTEP Ltd at the end of Q3 2022 but not at the end of Q2 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Balyasny Asset Management LLC | 35,173 | $55.0K | 0.00% |
| Integrated Advisors Network LLC | 13,000 | $20.0K | 0.00% |
| UBS Group AG | 10,585 | $17.0K | 0.00% |
Sold out (4)
Institutions that held IMMUTEP Ltd at the end of Q2 2022 and filed for Q3 2022 without it.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Trellus Management Company, LLC | 100,950 | $205.0K |
| State Street Corp | 55,053 | $112.0K |
| Saturna Capital CORP | 20,500 | $42.0K |
| Captrust Financial Advisors | 1,860 | $4.00K |